Suzhou Langyi Biomedical Research Co., Ltd.

Suzhou Langyi Biomedical Research Co., Ltd. is a professional company engaged in new drug research and development, patent drug creation and imitation. Its main business is drug registration, drug consistency evaluation, and joint development and cooperation of pharmaceutical research and production projects. The registered capital is 27.1484 million yuan. Langyi's tenet: Market-oriented, technology-supported, and a pioneer in China's pharmaceutical industry MAH. Company's profit model: Develop and declare products by ourselves, entrust production, and sell by ourselves. The company is located on the second floor of Building 5, Changjiang Delta Innovation Medical Technology Industrial Park, No. 777 Kangyuan Road, Xiangcheng Economic and Technological Development Zone, Suzhou. It has a research and development team of more than 30 people, and the backbone has rich experience in drug research and development and production. In 2013, it was rated as the Engineering Technology Center for Anti-Neuralgia Sustained-Release Drugs and a private technology enterprise by the Suzhou Science and Technology Bureau.